FN2 Earnings Intelligence
Solventum (SOLV) earnings history
Solventum Corporation (SOLV) quarterly earnings scorecards, market reactions, transcript intelligence, and historical context.
Earnings History
Solventum Corporation
The supplied analysis supports a constructive but conditional view of Solventum's operating trajectory: strong Q2 execution, raised guidance, Acera's growth, and progress on the 3M separation support the case for earnings growth and resilient demand. The case still depends on navigating the Q3 advanced-order reversal, completing ERP and HIS separation work, and containing tariff, inflation, and separation-related pressures.
Solventum Corporation
Solventum's first-quarter FY2026 results beat consensus on both lines, with EPS of $1.48 (vs. $1.35 estimated) and revenue of $2.01 billion (vs. $1.97 billion estimated). The beat was underpinned by approximately 4% normalized organic growth, 80 basis points of operating margin expansion, and early contribution from the Acera acquisition. Management maintained full-year guidance and signaled EPS would trend toward the high end of the $6.40-$6.60 range. The 3M separation is advancing with 50% of transition service agreements extinguished and ERP migrations underway, though timing is expected to shift over $100 million of sales into Q2 with a reverse effect in Q3. The stock has drifted approximately 16% higher since the report, suggesting the market is rewarding the operational progress and capital return.
Solventum Corporation
The supplied analysis supports a cautiously constructive view of Solventum’s operating trajectory: organic growth is running above internal targets, while new products, cost savings and AI-enabled autonomous coding provide potential growth and margin levers. The case remains dependent on execution of ERP separation, cost savings and integration plans.
Solventum Corporation
The supplied analysis supports a constructive operating thesis: volume growth, product launches, restructuring and balance-sheet improvement strengthen the outlook, but tariff exposure and execution risks temper confidence.
Solventum Corporation
The current analysis supports a constructive but qualified view of Solventum's operating trajectory: management reported 2.8% organic sales growth, raised FY2025 guidance, and highlighted product launches and separation milestones. The evidence is about operating progress, not a forecast of the stock's one-year return.
Solventum Corporation
The supplied analysis supports a cautiously constructive view: stronger organic growth, product launches and commercial execution improved the near-term trajectory, but tariff exposure and transformation execution risks temper the outlook.
Get the SOLV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.